“Health-Related Quality of Life (HRQL) in Patients With Advanced Cutaneous Squamous Cell Carcinoma (CSCC) Treated With Cemiplimab: Post Hoc Exploratory Analysis of a Phase 2 Clinical Trial”. SKIN The Journal of Cutaneous Medicine, vol. 4, no. 6, Oct. 2020, p. s122, https://doi.org/10.25251/skin.4.supp.122.